Thomas Moore

In this insightful discussion, Thomas Moore, Sky's science correspondent, dives into the controversial realm of weight loss drugs like Ozempic and Wegovy. He highlights alarming new data linking these medications to serious health risks, including pancreatitis. Personal stories, like that of Lorna, reveal the dangerous side effects experienced by users. The conversation also touches on the importance of understanding genetic factors in treatment efficiency and the societal shift towards these quick-fix solutions, questioning their long-term safety.

Thomas Moore, Sky News Science Correspondent, shares insights on geoengineering and its potential to combat climate change. He discusses a groundbreaking experiment to thicken Arctic ice using freezing seawater, exploring the innovative yet controversial nature of such methods. The conversation delves into the tension between relying on traditional decarbonization strategies and these experimental technologies. Moore also highlights the challenges of public engagement in climate initiatives and the urgent need to address the impact of climate change on the polar regions.

Thomas Moore, Sky's science and medical correspondent, delves into how AI tools like Delphi could revolutionize disease prediction in the NHS. He discusses the potential of AI to predict chronic conditions years in advance, but raises concerns about patient reactions and implementation hurdles. Dr. Ben Maruthappu shares insights on how AI can assist frontline staff and support home care. They explore the balance between technological advancement and the essential human touch in healthcare, emphasizing the need for oversight and consistent systems.